missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DRAK1 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0051
This item is not returnable.
View return policy
Description
DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.
STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.
Specifications
9263 | |
purified | |
Human DRAK1 | |
-20°C | |
Liquid | |
Blocking Assay, Control | |
No | |
Peptide | |
RUO - research use only |
Human | |
Q9UEE5 | |
200 μg/mL | |
Synthetic Peptide | |
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
STK17A | |
0.02% sodium azide | |
50 μg | |
PBS |
Product Suggestions
Customers who viewed this item also viewed.
Viewing 1-5 of 9
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human DRAK1 Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction